Table of Contents
Introduction
Abetalipoproteinemia (ABL) is a sporadic autosomal recessive disease defined by low or undetectable plasma cholesterol levels and low-density lipoprotein. The disease should not be confused with a deficiency in beta-lipoprotein. The cardinal features of the disease include fat malabsorption, spinocerebellar degeneration, acanthocyte red blood cells, and retinitis pigmentosa.
What Is Abetalipoproteinemia?
Abetalipoproteinemia is a sporadic autosomal recessive disease due to the virtual absence of apolipoprotein B-containing lipoproteins from plasma. Serious malabsorption of fat and fat-soluble vitamins, manifesting as growth retardation, neurological and neuromuscular findings, and retinal degeneration, are the major clinical manifestations of this disorder. Abetalipoproteinemia is an inherited condition that resists the body's dietary fat absorption. Not cured on time may trigger vitamin deficiencies, causing long-term health effects. The vitamins and dietary fats are thus important for the growth and development of organs and tissues, including the brain. Bassen-Kornzweig syndrome, acanthocytosis, and apolipoprotein B deficiency are the other common names of abetalipoproteinemia. It is not contagious due to defective genes, which run among families.
This is one of the rare congenital disorders. Only 100 cases in the world population have been reported with Abetalipoproteinemia. The probability of abetalipoproteinemia is equal for both males and females. There are no ethnic, racial, or geographical preferences. Symptoms of abetalipoproteinemia vary from one person to another. They are related to the infant's development, coordination issues, and slurred speech in adults. Because of ABL, the eyes, the nervous system, the gastrointestinal tract, and blood are affected.
What Are the Common Symptoms of Abetalipoproteinemia?
The common symptoms include the following:
-
Dietary Fat Malabsorption: Impaired absorption of dietary fat can lead to steatorrhea (fatty, foul-smelling feces) and chronic diarrhea.
-
Failure to Thrive: Poor growth and developmental delays due to malnutrition can be observed in infants and children with abetalipoproteinemia.
Fat-soluble vitamin deficiencies are as follows:
-
Vitamin A: This leads to impaired vision, night blindness, and other eye manifestations.
-
Vitamin D: Rickets are a condition characterized by softening and weakening bones.
-
Vitamin E: This may lead to neurological problems like muscle weakness, coordination, and balance. Vitamin K deficiency can cause problems in your blood clotting mechanism, increasing bleeding.
-
Neurologic Symptoms: You can also suffer from progressive neurologic issues, including ataxia, peripheral neuropathy, and problems with speech.
-
RP is considered a progressive eye disease with vision loss and, at times, complete blindness. Acanthocytosis, abnormal spiky red cells, also known as acanthocytes, may be present with a prospect of leading to hemolytic anemia.
-
Symptoms of muscle weakness and difficulty walking can also result from deficiencies of fat-soluble vitamins, mainly vitamin E.
How Is Abetalipoproteinemia Diagnosed?
Abetalipoproteinemia is diagnosed with a set of tests.
-
Tests of Metabolic Blood: A series of tests are carried out to detect vitamins A, D, E, and K, and metabolic changes are diagnosed. Sometimes, apolipoprotein B levels are also tested. The levels vary among lipemic diseases and ABL. In a detailed search, even cholesterol levels and blood complete counts are checked.
-
Genetic Blood Tests: If you have a family history of ABL, your doctor may ask you to get a test for mutations in the MTP gene, one of the genes responsible for ABL. This may help in two ways: it may help determine whether you have ABL and whether your partner needs to be tested before having children.
-
Other Test: Diagnosing ABL may require more than one visit to the doctor. Identifying whether symptoms are from ABL or others also takes some time. Additional testing is recommended to understand how ABL affects a body. The tests include electromyography tests, eye examinations, and stool sample examinations.
-
The neurological examination and the testing of the red blood cells, which may reveal the presence of prickly spikes on the surface that contribute to the aberrant shape resulting in acanthocytosis, are included in the clinical examination. The liver tests for abnormalities, intestinal biopsy, and upper GI endoscopy to look for elevated adiposity in epithelial cells. The liver biopsy is utilized to examine the fatty accumulation.
What Is the Treatment for Abetalipoproteinemia?
-
Abetalipoproteinemia treatment is symptomatic and addresses the exact symptoms each individual presents. A panel of experts may have to be considered when devising a course of treatment. Treatment planning may require neurologists, gastroenterologists, ophthalmologists, hepatologists, neurologists, and those involved in studying fats, including nutritionists; these services must be in collaboration and well planned. Such patients need close observation every six to twelve months.
-
Neurological and ophthalmological follow-up is needed to look for neurological or ophthalmological deterioration. Annual blood investigations concerning amino transaminases are required for evidence of liver damage. Hepatic ultrasonography can be done to diagnose fatty liver. Echocardiography should be repeated every three years to ensure proper heart functioning.
-
Most affected patients are usually effectively treated with dietary therapy, which consists of a diet with minimal intake of long-chain saturated fatty acids. A decrease in dietary fat intake tends to alleviate gastrointestinal symptoms. The patients must receive nutrition counseling regularly. Infants' diets may be supplemented with medium-chain fatty acids, which can be transported in the bloodstream without the aid of apoB-containing lipoproteins to promote growth and development.
-
Many of the symptoms related to abetalipoproteinemia can be prevented or treated with high oral doses of the fat-soluble vitamins A, E, and K. For instance, supplementation of vitamin A, along with therapy with vitamin E, may prevent neurological and retinal defects associated with this disorder. Supplementation with vitamin D may ease symptoms related to bone development.
-
The dose should be adjusted according to neurological tests, ophthalmological examinations, and blood panels. It must be remembered that it is not always possible to measure vitamin E levels in these high-dose supplement patients. However, patients must continue on their vitamin E medication.
Conclusion
Each patient's prognosis is quite different. Some neurological and ophthalmologic deficiencies may be lessened with early diagnosis, management, and supplementation of fat-soluble vitamins. Regarding pharmacologic intervention of the fat-soluble vitamins, patients should be followed closely. Other treatments are symptomatic and supportive. Abetalipoproteinemia is a degenerative genetic disorder caused by mutations in the MTP gene, characterized by the absence of lipoproteins containing apolipoprotein B and several extremely unusual clinical features. Genetic investigations and clinical examinations would confirm the diagnosis; treatment would consist of high doses of supplements of fat-soluble vitamins and dietary changes. In the case of early diagnosis and good compliance, a better prognosis with good quality of life can be expected when treating the disorder.
